aluates Reports

$ 0.0

Automative

Global Cancer Genome Analysis Market Research Report 2025

Published Date: 2025-06-30

Report Code: QYRE-Auto-4P8830

Global Cancer Genome Analysis Market Insights Forecast to 2028

BUY CHAPTERS

Global Cancer Genome Analysis Market Research Report 2025

Code: QYRE-Auto-4P8830

Report

2025-06-30

Pages:113

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Cancer Genome Analysis Market

The global market for Cancer Genome Analysis was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Cancer Genome Analysis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cancer Genome Analysis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Cancer Genome Analysis in Clinical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Cancer Genome Analysis include Abbott Diagnostics, AccuraGen Inc, Acuamark Diagnostics, Admera Health, LLC, Agena Bioscience, Inc, Agilent, Almac Diagnostics, Amoy Diagnostics Co., Ltd., Anchor Dx, ANGLE plc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cancer Genome Analysis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Genome Analysis.

The Cancer Genome Analysis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Genome Analysis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Genome Analysis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cancer Genome Analysis Market Report

Report Metric	Details
Report Name	Cancer Genome Analysis Market
Segment by Type	Solid Tissue Analysis Liquid Tissue Analysis
Segment by Application	Clinical Pharmaceutical Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Diagnostics, AccuraGen Inc, Acuamark Diagnostics, Admera Health, LLC, Agena Bioscience, Inc, Agilent, Almac Diagnostics, Amoy Diagnostics Co., Ltd., Anchor Dx, ANGLE plc, ApoCell, Inc., ArcherDx, Inc, Asuragen, AVIVA Biosciences, Baylor Miraca Genetics Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company, BGI Genomics Co. Ltd, Bioarray Genetics, Biocartis, Biocept, Inc, Biodesix Inc, BioFluidica, bioMérieux Diagnostics, Bioneer Corporation, Bio-Rad Laboratories, Inc, Bio-Techne
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Genome Analysis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cancer Genome Analysis Market report?

Ans: The main players in the Cancer Genome Analysis Market are Abbott Diagnostics, AccuraGen Inc, Acuamark Diagnostics, Admera Health, LLC, Agena Bioscience, Inc, Agilent, Almac Diagnostics, Amoy Diagnostics Co., Ltd., Anchor Dx, ANGLE plc, ApoCell, Inc., ArcherDx, Inc, Asuragen, AVIVA Biosciences, Baylor Miraca Genetics Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company, BGI Genomics Co. Ltd, Bioarray Genetics, Biocartis, Biocept, Inc, Biodesix Inc, BioFluidica, bioMérieux Diagnostics, Bioneer Corporation, Bio-Rad Laboratories, Inc, Bio-Techne

What are the Application segmentation covered in the Cancer Genome Analysis Market report?

Ans: The Applications covered in the Cancer Genome Analysis Market report are Clinical, Pharmaceutical, Research

What are the Type segmentation covered in the Cancer Genome Analysis Market report?

Ans: The Types covered in the Cancer Genome Analysis Market report are Solid Tissue Analysis, Liquid Tissue Analysis

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Genome Analysis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Solid Tissue Analysis

1.2.3 Liquid Tissue Analysis

1.3 Market by Application

1.3.1 Global Cancer Genome Analysis Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Clinical

1.3.3 Pharmaceutical

1.3.4 Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer Genome Analysis Market Perspective (2020-2031)

2.2 Global Cancer Genome Analysis Growth Trends by Region

2.2.1 Global Cancer Genome Analysis Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Cancer Genome Analysis Historic Market Size by Region (2020-2025)

2.2.3 Cancer Genome Analysis Forecasted Market Size by Region (2026-2031)

2.3 Cancer Genome Analysis Market Dynamics

2.3.1 Cancer Genome Analysis Industry Trends

2.3.2 Cancer Genome Analysis Market Drivers

2.3.3 Cancer Genome Analysis Market Challenges

2.3.4 Cancer Genome Analysis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cancer Genome Analysis Players by Revenue

3.1.1 Global Top Cancer Genome Analysis Players by Revenue (2020-2025)

3.1.2 Global Cancer Genome Analysis Revenue Market Share by Players (2020-2025)

3.2 Global Cancer Genome Analysis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cancer Genome Analysis Revenue

3.4 Global Cancer Genome Analysis Market Concentration Ratio

3.4.1 Global Cancer Genome Analysis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Genome Analysis Revenue in 2024

3.5 Global Key Players of Cancer Genome Analysis Head office and Area Served

3.6 Global Key Players of Cancer Genome Analysis, Product and Application

3.7 Global Key Players of Cancer Genome Analysis, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Genome Analysis Breakdown Data by Type

4.1 Global Cancer Genome Analysis Historic Market Size by Type (2020-2025)

4.2 Global Cancer Genome Analysis Forecasted Market Size by Type (2026-2031)

5 Cancer Genome Analysis Breakdown Data by Application

5.1 Global Cancer Genome Analysis Historic Market Size by Application (2020-2025)

5.2 Global Cancer Genome Analysis Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Cancer Genome Analysis Market Size (2020-2031)

6.2 North America Cancer Genome Analysis Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Cancer Genome Analysis Market Size by Country (2020-2025)

6.4 North America Cancer Genome Analysis Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cancer Genome Analysis Market Size (2020-2031)

7.2 Europe Cancer Genome Analysis Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Cancer Genome Analysis Market Size by Country (2020-2025)

7.4 Europe Cancer Genome Analysis Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cancer Genome Analysis Market Size (2020-2031)

8.2 Asia-Pacific Cancer Genome Analysis Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Cancer Genome Analysis Market Size by Region (2020-2025)

8.4 Asia-Pacific Cancer Genome Analysis Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cancer Genome Analysis Market Size (2020-2031)

9.2 Latin America Cancer Genome Analysis Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Cancer Genome Analysis Market Size by Country (2020-2025)

9.4 Latin America Cancer Genome Analysis Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cancer Genome Analysis Market Size (2020-2031)

10.2 Middle East & Africa Cancer Genome Analysis Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Cancer Genome Analysis Market Size by Country (2020-2025)

10.4 Middle East & Africa Cancer Genome Analysis Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Diagnostics

11.1.1 Abbott Diagnostics Company Details

11.1.2 Abbott Diagnostics Business Overview

11.1.3 Abbott Diagnostics Cancer Genome Analysis Introduction

11.1.4 Abbott Diagnostics Revenue in Cancer Genome Analysis Business (2020-2025)

11.1.5 Abbott Diagnostics Recent Development

11.2 AccuraGen Inc

11.2.1 AccuraGen Inc Company Details

11.2.2 AccuraGen Inc Business Overview

11.2.3 AccuraGen Inc Cancer Genome Analysis Introduction

11.2.4 AccuraGen Inc Revenue in Cancer Genome Analysis Business (2020-2025)

11.2.5 AccuraGen Inc Recent Development

11.3 Acuamark Diagnostics

11.3.1 Acuamark Diagnostics Company Details

11.3.2 Acuamark Diagnostics Business Overview

11.3.3 Acuamark Diagnostics Cancer Genome Analysis Introduction

11.3.4 Acuamark Diagnostics Revenue in Cancer Genome Analysis Business (2020-2025)

11.3.5 Acuamark Diagnostics Recent Development

11.4 Admera Health, LLC

11.4.1 Admera Health, LLC Company Details

11.4.2 Admera Health, LLC Business Overview

11.4.3 Admera Health, LLC Cancer Genome Analysis Introduction

11.4.4 Admera Health, LLC Revenue in Cancer Genome Analysis Business (2020-2025)

11.4.5 Admera Health, LLC Recent Development

11.5 Agena Bioscience, Inc

11.5.1 Agena Bioscience, Inc Company Details

11.5.2 Agena Bioscience, Inc Business Overview

11.5.3 Agena Bioscience, Inc Cancer Genome Analysis Introduction

11.5.4 Agena Bioscience, Inc Revenue in Cancer Genome Analysis Business (2020-2025)

11.5.5 Agena Bioscience, Inc Recent Development

11.6 Agilent

11.6.1 Agilent Company Details

11.6.2 Agilent Business Overview

11.6.3 Agilent Cancer Genome Analysis Introduction

11.6.4 Agilent Revenue in Cancer Genome Analysis Business (2020-2025)

11.6.5 Agilent Recent Development

11.7 Almac Diagnostics

11.7.1 Almac Diagnostics Company Details

11.7.2 Almac Diagnostics Business Overview

11.7.3 Almac Diagnostics Cancer Genome Analysis Introduction

11.7.4 Almac Diagnostics Revenue in Cancer Genome Analysis Business (2020-2025)

11.7.5 Almac Diagnostics Recent Development

11.8 Amoy Diagnostics Co., Ltd.

11.8.1 Amoy Diagnostics Co., Ltd. Company Details

11.8.2 Amoy Diagnostics Co., Ltd. Business Overview

11.8.3 Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Introduction

11.8.4 Amoy Diagnostics Co., Ltd. Revenue in Cancer Genome Analysis Business (2020-2025)

11.8.5 Amoy Diagnostics Co., Ltd. Recent Development

11.9 Anchor Dx

11.9.1 Anchor Dx Company Details

11.9.2 Anchor Dx Business Overview

11.9.3 Anchor Dx Cancer Genome Analysis Introduction

11.9.4 Anchor Dx Revenue in Cancer Genome Analysis Business (2020-2025)

11.9.5 Anchor Dx Recent Development

11.10 ANGLE plc

11.10.1 ANGLE plc Company Details

11.10.2 ANGLE plc Business Overview

11.10.3 ANGLE plc Cancer Genome Analysis Introduction

11.10.4 ANGLE plc Revenue in Cancer Genome Analysis Business (2020-2025)

11.10.5 ANGLE plc Recent Development

11.11 ApoCell, Inc.

11.11.1 ApoCell, Inc. Company Details

11.11.2 ApoCell, Inc. Business Overview

11.11.3 ApoCell, Inc. Cancer Genome Analysis Introduction

11.11.4 ApoCell, Inc. Revenue in Cancer Genome Analysis Business (2020-2025)

11.11.5 ApoCell, Inc. Recent Development

11.12 ArcherDx, Inc

11.12.1 ArcherDx, Inc Company Details

11.12.2 ArcherDx, Inc Business Overview

11.12.3 ArcherDx, Inc Cancer Genome Analysis Introduction

11.12.4 ArcherDx, Inc Revenue in Cancer Genome Analysis Business (2020-2025)

11.12.5 ArcherDx, Inc Recent Development

11.13 Asuragen

11.13.1 Asuragen Company Details

11.13.2 Asuragen Business Overview

11.13.3 Asuragen Cancer Genome Analysis Introduction

11.13.4 Asuragen Revenue in Cancer Genome Analysis Business (2020-2025)

11.13.5 Asuragen Recent Development

11.14 AVIVA Biosciences

11.14.1 AVIVA Biosciences Company Details

11.14.2 AVIVA Biosciences Business Overview

11.14.3 AVIVA Biosciences Cancer Genome Analysis Introduction

11.14.4 AVIVA Biosciences Revenue in Cancer Genome Analysis Business (2020-2025)

11.14.5 AVIVA Biosciences Recent Development

11.15 Baylor Miraca Genetics Laboratories

11.15.1 Baylor Miraca Genetics Laboratories Company Details

11.15.2 Baylor Miraca Genetics Laboratories Business Overview

11.15.3 Baylor Miraca Genetics Laboratories Cancer Genome Analysis Introduction

11.15.4 Baylor Miraca Genetics Laboratories Revenue in Cancer Genome Analysis Business (2020-2025)

11.15.5 Baylor Miraca Genetics Laboratories Recent Development

11.16 Beckman Coulter, Inc.

11.16.1 Beckman Coulter, Inc. Company Details

11.16.2 Beckman Coulter, Inc. Business Overview

11.16.3 Beckman Coulter, Inc. Cancer Genome Analysis Introduction

11.16.4 Beckman Coulter, Inc. Revenue in Cancer Genome Analysis Business (2020-2025)

11.16.5 Beckman Coulter, Inc. Recent Development

11.17 Becton, Dickinson and Company

11.17.1 Becton, Dickinson and Company Company Details

11.17.2 Becton, Dickinson and Company Business Overview

11.17.3 Becton, Dickinson and Company Cancer Genome Analysis Introduction

11.17.4 Becton, Dickinson and Company Revenue in Cancer Genome Analysis Business (2020-2025)

11.17.5 Becton, Dickinson and Company Recent Development

11.18 BGI Genomics Co. Ltd

11.18.1 BGI Genomics Co. Ltd Company Details

11.18.2 BGI Genomics Co. Ltd Business Overview

11.18.3 BGI Genomics Co. Ltd Cancer Genome Analysis Introduction

11.18.4 BGI Genomics Co. Ltd Revenue in Cancer Genome Analysis Business (2020-2025)

11.18.5 BGI Genomics Co. Ltd Recent Development

11.19 Bioarray Genetics

11.19.1 Bioarray Genetics Company Details

11.19.2 Bioarray Genetics Business Overview

11.19.3 Bioarray Genetics Cancer Genome Analysis Introduction

11.19.4 Bioarray Genetics Revenue in Cancer Genome Analysis Business (2020-2025)

11.19.5 Bioarray Genetics Recent Development

11.20 Biocartis

11.20.1 Biocartis Company Details

11.20.2 Biocartis Business Overview

11.20.3 Biocartis Cancer Genome Analysis Introduction

11.20.4 Biocartis Revenue in Cancer Genome Analysis Business (2020-2025)

11.20.5 Biocartis Recent Development

11.21 Biocept, Inc

11.21.1 Biocept, Inc Company Details

11.21.2 Biocept, Inc Business Overview

11.21.3 Biocept, Inc Cancer Genome Analysis Introduction

11.21.4 Biocept, Inc Revenue in Cancer Genome Analysis Business (2020-2025)

11.21.5 Biocept, Inc Recent Development

11.22 Biodesix Inc

11.22.1 Biodesix Inc Company Details

11.22.2 Biodesix Inc Business Overview

11.22.3 Biodesix Inc Cancer Genome Analysis Introduction

11.22.4 Biodesix Inc Revenue in Cancer Genome Analysis Business (2020-2025)

11.22.5 Biodesix Inc Recent Development

11.23 BioFluidica

11.23.1 BioFluidica Company Details

11.23.2 BioFluidica Business Overview

11.23.3 BioFluidica Cancer Genome Analysis Introduction

11.23.4 BioFluidica Revenue in Cancer Genome Analysis Business (2020-2025)

11.23.5 BioFluidica Recent Development

11.24 bioMérieux Diagnostics

11.24.1 bioMérieux Diagnostics Company Details

11.24.2 bioMérieux Diagnostics Business Overview

11.24.3 bioMérieux Diagnostics Cancer Genome Analysis Introduction

11.24.4 bioMérieux Diagnostics Revenue in Cancer Genome Analysis Business (2020-2025)

11.24.5 bioMérieux Diagnostics Recent Development

11.25 Bioneer Corporation

11.25.1 Bioneer Corporation Company Details

11.25.2 Bioneer Corporation Business Overview

11.25.3 Bioneer Corporation Cancer Genome Analysis Introduction

11.25.4 Bioneer Corporation Revenue in Cancer Genome Analysis Business (2020-2025)

11.25.5 Bioneer Corporation Recent Development

11.26 Bio-Rad Laboratories, Inc

11.26.1 Bio-Rad Laboratories, Inc Company Details

11.26.2 Bio-Rad Laboratories, Inc Business Overview

11.26.3 Bio-Rad Laboratories, Inc Cancer Genome Analysis Introduction

11.26.4 Bio-Rad Laboratories, Inc Revenue in Cancer Genome Analysis Business (2020-2025)

11.26.5 Bio-Rad Laboratories, Inc Recent Development

11.27 Bio-Techne

11.27.1 Bio-Techne Company Details

11.27.2 Bio-Techne Business Overview

11.27.3 Bio-Techne Cancer Genome Analysis Introduction

11.27.4 Bio-Techne Revenue in Cancer Genome Analysis Business (2020-2025)

11.27.5 Bio-Techne Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Cancer Genome Analysis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Solid Tissue Analysis

Table 3. Key Players of Liquid Tissue Analysis

Table 4. Global Cancer Genome Analysis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Cancer Genome Analysis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Cancer Genome Analysis Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Cancer Genome Analysis Market Share by Region (2020-2025)

Table 8. Global Cancer Genome Analysis Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Cancer Genome Analysis Market Share by Region (2026-2031)

Table 10. Cancer Genome Analysis Market Trends

Table 11. Cancer Genome Analysis Market Drivers

Table 12. Cancer Genome Analysis Market Challenges

Table 13. Cancer Genome Analysis Market Restraints

Table 14. Global Cancer Genome Analysis Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Cancer Genome Analysis Market Share by Players (2020-2025)

Table 16. Global Top Cancer Genome Analysis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genome Analysis as of 2024)

Table 17. Ranking of Global Top Cancer Genome Analysis Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Cancer Genome Analysis Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Cancer Genome Analysis, Headquarters and Area Served

Table 20. Global Key Players of Cancer Genome Analysis, Product and Application

Table 21. Global Key Players of Cancer Genome Analysis, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Cancer Genome Analysis Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Cancer Genome Analysis Revenue Market Share by Type (2020-2025)

Table 25. Global Cancer Genome Analysis Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Cancer Genome Analysis Revenue Market Share by Type (2026-2031)

Table 27. Global Cancer Genome Analysis Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Cancer Genome Analysis Revenue Market Share by Application (2020-2025)

Table 29. Global Cancer Genome Analysis Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Cancer Genome Analysis Revenue Market Share by Application (2026-2031)

Table 31. North America Cancer Genome Analysis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Cancer Genome Analysis Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Cancer Genome Analysis Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Cancer Genome Analysis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Cancer Genome Analysis Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Cancer Genome Analysis Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Cancer Genome Analysis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Cancer Genome Analysis Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Cancer Genome Analysis Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Cancer Genome Analysis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Cancer Genome Analysis Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Cancer Genome Analysis Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Cancer Genome Analysis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Cancer Genome Analysis Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Cancer Genome Analysis Market Size by Country (2026-2031) & (US$ Million)

Table 46. Abbott Diagnostics Company Details

Table 47. Abbott Diagnostics Business Overview

Table 48. Abbott Diagnostics Cancer Genome Analysis Product

Table 49. Abbott Diagnostics Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 50. Abbott Diagnostics Recent Development

Table 51. AccuraGen Inc Company Details

Table 52. AccuraGen Inc Business Overview

Table 53. AccuraGen Inc Cancer Genome Analysis Product

Table 54. AccuraGen Inc Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 55. AccuraGen Inc Recent Development

Table 56. Acuamark Diagnostics Company Details

Table 57. Acuamark Diagnostics Business Overview

Table 58. Acuamark Diagnostics Cancer Genome Analysis Product

Table 59. Acuamark Diagnostics Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 60. Acuamark Diagnostics Recent Development

Table 61. Admera Health, LLC Company Details

Table 62. Admera Health, LLC Business Overview

Table 63. Admera Health, LLC Cancer Genome Analysis Product

Table 64. Admera Health, LLC Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 65. Admera Health, LLC Recent Development

Table 66. Agena Bioscience, Inc Company Details

Table 67. Agena Bioscience, Inc Business Overview

Table 68. Agena Bioscience, Inc Cancer Genome Analysis Product

Table 69. Agena Bioscience, Inc Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 70. Agena Bioscience, Inc Recent Development

Table 71. Agilent Company Details

Table 72. Agilent Business Overview

Table 73. Agilent Cancer Genome Analysis Product

Table 74. Agilent Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 75. Agilent Recent Development

Table 76. Almac Diagnostics Company Details

Table 77. Almac Diagnostics Business Overview

Table 78. Almac Diagnostics Cancer Genome Analysis Product

Table 79. Almac Diagnostics Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 80. Almac Diagnostics Recent Development

Table 81. Amoy Diagnostics Co., Ltd. Company Details

Table 82. Amoy Diagnostics Co., Ltd. Business Overview

Table 83. Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Product

Table 84. Amoy Diagnostics Co., Ltd. Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 85. Amoy Diagnostics Co., Ltd. Recent Development

Table 86. Anchor Dx Company Details

Table 87. Anchor Dx Business Overview

Table 88. Anchor Dx Cancer Genome Analysis Product

Table 89. Anchor Dx Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 90. Anchor Dx Recent Development

Table 91. ANGLE plc Company Details

Table 92. ANGLE plc Business Overview

Table 93. ANGLE plc Cancer Genome Analysis Product

Table 94. ANGLE plc Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 95. ANGLE plc Recent Development

Table 96. ApoCell, Inc. Company Details

Table 97. ApoCell, Inc. Business Overview

Table 98. ApoCell, Inc. Cancer Genome Analysis Product

Table 99. ApoCell, Inc. Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 100. ApoCell, Inc. Recent Development

Table 101. ArcherDx, Inc Company Details

Table 102. ArcherDx, Inc Business Overview

Table 103. ArcherDx, Inc Cancer Genome Analysis Product

Table 104. ArcherDx, Inc Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 105. ArcherDx, Inc Recent Development

Table 106. Asuragen Company Details

Table 107. Asuragen Business Overview

Table 108. Asuragen Cancer Genome Analysis Product

Table 109. Asuragen Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 110. Asuragen Recent Development

Table 111. AVIVA Biosciences Company Details

Table 112. AVIVA Biosciences Business Overview

Table 113. AVIVA Biosciences Cancer Genome Analysis Product

Table 114. AVIVA Biosciences Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 115. AVIVA Biosciences Recent Development

Table 116. Baylor Miraca Genetics Laboratories Company Details

Table 117. Baylor Miraca Genetics Laboratories Business Overview

Table 118. Baylor Miraca Genetics Laboratories Cancer Genome Analysis Product

Table 119. Baylor Miraca Genetics Laboratories Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 120. Baylor Miraca Genetics Laboratories Recent Development

Table 121. Beckman Coulter, Inc. Company Details

Table 122. Beckman Coulter, Inc. Business Overview

Table 123. Beckman Coulter, Inc. Cancer Genome Analysis Product

Table 124. Beckman Coulter, Inc. Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 125. Beckman Coulter, Inc. Recent Development

Table 126. Becton, Dickinson and Company Company Details

Table 127. Becton, Dickinson and Company Business Overview

Table 128. Becton, Dickinson and Company Cancer Genome Analysis Product

Table 129. Becton, Dickinson and Company Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 130. Becton, Dickinson and Company Recent Development

Table 131. BGI Genomics Co. Ltd Company Details

Table 132. BGI Genomics Co. Ltd Business Overview

Table 133. BGI Genomics Co. Ltd Cancer Genome Analysis Product

Table 134. BGI Genomics Co. Ltd Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 135. BGI Genomics Co. Ltd Recent Development

Table 136. Bioarray Genetics Company Details

Table 137. Bioarray Genetics Business Overview

Table 138. Bioarray Genetics Cancer Genome Analysis Product

Table 139. Bioarray Genetics Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 140. Bioarray Genetics Recent Development

Table 141. Biocartis Company Details

Table 142. Biocartis Business Overview

Table 143. Biocartis Cancer Genome Analysis Product

Table 144. Biocartis Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 145. Biocartis Recent Development

Table 146. Biocept, Inc Company Details

Table 147. Biocept, Inc Business Overview

Table 148. Biocept, Inc Cancer Genome Analysis Product

Table 149. Biocept, Inc Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 150. Biocept, Inc Recent Development

Table 151. Biodesix Inc Company Details

Table 152. Biodesix Inc Business Overview

Table 153. Biodesix Inc Cancer Genome Analysis Product

Table 154. Biodesix Inc Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 155. Biodesix Inc Recent Development

Table 156. BioFluidica Company Details

Table 157. BioFluidica Business Overview

Table 158. BioFluidica Cancer Genome Analysis Product

Table 159. BioFluidica Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 160. BioFluidica Recent Development

Table 161. bioMérieux Diagnostics Company Details

Table 162. bioMérieux Diagnostics Business Overview

Table 163. bioMérieux Diagnostics Cancer Genome Analysis Product

Table 164. bioMérieux Diagnostics Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 165. bioMérieux Diagnostics Recent Development

Table 166. Bioneer Corporation Company Details

Table 167. Bioneer Corporation Business Overview

Table 168. Bioneer Corporation Cancer Genome Analysis Product

Table 169. Bioneer Corporation Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 170. Bioneer Corporation Recent Development

Table 171. Bio-Rad Laboratories, Inc Company Details

Table 172. Bio-Rad Laboratories, Inc Business Overview

Table 173. Bio-Rad Laboratories, Inc Cancer Genome Analysis Product

Table 174. Bio-Rad Laboratories, Inc Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 175. Bio-Rad Laboratories, Inc Recent Development

Table 176. Bio-Techne Company Details

Table 177. Bio-Techne Business Overview

Table 178. Bio-Techne Cancer Genome Analysis Product

Table 179. Bio-Techne Revenue in Cancer Genome Analysis Business (2020-2025) & (US$ Million)

Table 180. Bio-Techne Recent Development

Table 181. Research Programs/Design for This Report

Table 182. Key Data Information from Secondary Sources

Table 183. Key Data Information from Primary Sources

Table 184. Authors List of This Report

List of Figures

Figure 1. Cancer Genome Analysis Picture

Figure 2. Global Cancer Genome Analysis Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Cancer Genome Analysis Market Share by Type: 2024 VS 2031

Figure 4. Solid Tissue Analysis Features

Figure 5. Liquid Tissue Analysis Features

Figure 6. Global Cancer Genome Analysis Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Cancer Genome Analysis Market Share by Application: 2024 VS 2031

Figure 8. Clinical Case Studies

Figure 9. Pharmaceutical Case Studies

Figure 10. Research Case Studies

Figure 11. Cancer Genome Analysis Report Years Considered

Figure 12. Global Cancer Genome Analysis Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Cancer Genome Analysis Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Cancer Genome Analysis Market Share by Region: 2024 VS 2031

Figure 15. Global Cancer Genome Analysis Market Share by Players in 2024

Figure 16. Global Top Cancer Genome Analysis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genome Analysis as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Cancer Genome Analysis Revenue in 2024

Figure 18. North America Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Cancer Genome Analysis Market Share by Country (2020-2031)

Figure 20. United States Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Cancer Genome Analysis Market Share by Country (2020-2031)

Figure 24. Germany Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Cancer Genome Analysis Market Share by Region (2020-2031)

Figure 32. China Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Cancer Genome Analysis Market Share by Country (2020-2031)

Figure 40. Mexico Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Cancer Genome Analysis Market Share by Country (2020-2031)

Figure 44. Turkey Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Cancer Genome Analysis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Abbott Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 48. AccuraGen Inc Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 49. Acuamark Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 50. Admera Health, LLC Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 51. Agena Bioscience, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 52. Agilent Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 53. Almac Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 54. Amoy Diagnostics Co., Ltd. Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 55. Anchor Dx Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 56. ANGLE plc Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 57. ApoCell, Inc. Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 58. ArcherDx, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 59. Asuragen Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 60. AVIVA Biosciences Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 61. Baylor Miraca Genetics Laboratories Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 62. Beckman Coulter, Inc. Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 63. Becton, Dickinson and Company Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 64. BGI Genomics Co. Ltd Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 65. Bioarray Genetics Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 66. Biocartis Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 67. Biocept, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 68. Biodesix Inc Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 69. BioFluidica Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 70. bioMérieux Diagnostics Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 71. Bioneer Corporation Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 72. Bio-Rad Laboratories, Inc Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 73. Bio-Techne Revenue Growth Rate in Cancer Genome Analysis Business (2020-2025)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Cancer Genome Analysis Market Research Report 2025

Published Date: 2025-06-30

Report Code: QYRE-Auto-4P8830

Global Cancer Genome Analysis Market Research Report 2025

FEATURED COMPANIES

Cancer Genome Analysis Market

Scope of Cancer Genome Analysis Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Cancer Genome Analysis Market report?

What are the Application segmentation covered in the Cancer Genome Analysis Market report?

What are the Type segmentation covered in the Cancer Genome Analysis Market report?

FEATURED COMPANIES